Human Epidermal growth factor Receptor 2 (HER2) from ACROBiosystems

Her2 Molecule Information

Name:Receptor protein-tyrosine kinase erbB-2
Target Synonym:HER2 ?Tyrosine kinase-type cell surface receptor HER2?MLN19?Metastatic lymph node gene 19 protein?ERBB2?Proto-oncogene Neu?p185erbB2?CD_antigen=CD340?Proto-oncogene c-ErbB-2?MLN 19?NEU?Receptor tyrosine-protein kinase erbB-2?NGL
Number of Launched Drugs:20
Number of Drugs in Clinical Trials:127
Lastest Research Phase:Approved

Her2 Molecule Synonym Name

ERBB2, CD340, HER-2/neu, HER2, MLN19, NEU, NGL, TKR1

Her2 Molecule Background

Human Epidermal growth factor Receptor 2 (HER2) is also called ERBB2, HER-2,HER-2 /neu, NEU, NGL,TKR1 and c-erb B2,and is a protein giving higher aggressiveness in breast cancers. It is a member of the ErbB protein family, more commonly known as the epidermal growth factor receptor family. HER2 is a cell membrane surface-bound receptor tyrosine kinase and is normally involved in the signal transduction pathways leading to cell growth and differentiation.

HER2 is thought to be an orphan receptor, with none of the EGF family of ligands able to activate it. Approximately 30% of breast cancers have an amplification of the HER2 gene or overexpression of its protein product. Overexpression of this receptor in breast cancer is associated with increased disease recurrence and worse prognosis. HER2 appears to play roles in development, cancer,communication at the neuromuscular junction andregulation of cell growth and differentiation .

Her2 References